0001193125-16-458821.txt : 20160211 0001193125-16-458821.hdr.sgml : 20160211 20160211102400 ACCESSION NUMBER: 0001193125-16-458821 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20160205 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160211 DATE AS OF CHANGE: 20160211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 161408810 BUSINESS ADDRESS: STREET 1: 5959 S SHERWOOD FOREST BLVD CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 5959 S SHERWOOD FOREST BLVD CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d137301d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 11, 2016 (February 5, 2016)

Commission File Number: 0-24260

 

 

 

LOGO

Amedisys, Inc.

(Exact Name of Registrant as specified in its Charter)

 

 

 

Delaware   11-3131700

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816

(Address of principal executive offices, including zip code)

(225) 292-2031 or (800) 467-2662

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Section 1 – Registrant’s Business and Operations

Item 1.01. Entry into a Material Definitive Agreement

On February 5, 2016, Amedisys, Inc. (we or the “Company”) entered into an Equity Purchase Agreement (the “Agreement”) with Michael Trigilio, as Seller, to acquire all of the issued and outstanding equity interests in (i) Associated Home Care, Inc. (“AHC”) and (ii) Elder Home Options, LLC (“EHO,” and, together with AHC, the “Acquired Companies”), for a base purchase price of $28.0 million in cash, subject to customary purchase price adjustments at closing for working capital, cash indebtedness and transaction expenses.

AHC, founded in 1991, is a provider of private duty services in the Greater Boston, Massachusetts area. Its 1,500 employees deliver care to 5,000 seniors daily in homes throughout Eastern, Central, and Southern Massachusetts. AHC’s corporate location is in North Andover, Massachusetts and maintains branch offices in Beverly, Boston, Burlington, Leominster, Marblehead, Middleboro, Springfield, Worcester and Fall River, Massachusetts. Mr. Trigilio, along with his management team, will continue to lead AHC, and Mr. Trigilio will oversee the Company’s new Personal Care Division.

As additional consideration for the sale of the Acquired Companies, Mr. Trigilio shall be eligible, on a contingent basis, to receive payments (each a “Contingent Payment”) based on the achievement by the Acquired Companies of identified minimum EBITDA thresholds for five measurement periods ending on each of the first through fifth anniversaries of the closing date. If the Acquired Companies’ EBITDA exceeds the minimum EBITDA target for the then-applicable measurement period, Mr. Trigilio will be eligible to receive a Contingent Payment in accordance with a formula stated within the Agreement. Mr. Trigilio’s ability to receive such payments is linked to employment status, and the total number of payments made over the five-year measurement period shall not exceed $10.1 million in the aggregate (prior to any withholdings required by law and to be reported as compensation by Mr. Trigilio). Should the full $10.1 million in Contingent Payments be earned at the end of the final measurement period, the total consideration received by Mr. Trigilio will equal approximately five times adjusted EBITDA.

For purposes of the Contingent Payment calculations, “EBITDA” means, for the applicable measurement period, the net income before interest expense, tax expense, depreciation expense and amortization expense of the Acquired Companies and their subsidiaries, on a combined basis, calculated in accordance with GAAP and subject to certain adjustments, as further described in the Agreement.

The transaction is subject to customary closing conditions, including receipt of certain regulatory approvals. Other than the Agreement, there is no known relationship between us or any of our affiliates, and any of Mr. Trigilio, AHC or EHO. The parties expect to close the transaction on March 1, 2016.

Section 7 – Regulation FD

Item 7.01. Regulation FD Disclosure

On February 11, 2016, the Company issued a press release titled “Amedisys Announces Definitive Agreement to Acquire Associated Home Care,” a copy of which is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Section 9 - Financial Statements and Exhibits

Item 9.01.     Financial Statements and Exhibits

 

(d) Exhibits.

 

99.1    Press Release dated February 11, 2016 titled “Amedisys Announces Definitive Agreement to Acquire Associated Home Care” (furnished only)

 

2


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMEDISYS, INC.

 

By:  

/S/ Paul B. Kusserow

  Paul B. Kusserow
  President and Chief Executive Officer
DATE:   February 11, 2016

 

3


Exhibit Index

 

99.1    Press Release dated February 11, 2016 titled “Amedisys Announces Definitive Agreement to Acquire Associated Home Care” (furnished only)

 

4

EX-99.1 2 d137301dex991.htm EX-99.1 EX-99.1
LOGO    Exhibit 99.1

Amedisys Announces Definitive Agreement to Acquire Associated Home Care

Strategic Acquisition in Private Duty Adds to Amedisys’ Capabilities to Care for Patients in the Home

BATON ROUGE, La., February 11, 2016 – Amedisys, Inc. (NASDAQ: AMED), one of the nation’s leading home health care and hospice companies, today announced that it has signed a definitive agreement to acquire Associated Home Care, a private-duty home healthcare agency headquartered in North Andover, Massachusetts. Under the terms of the agreement, Amedisys will acquire 100% of the ownership interests in Associated Home Care for $28 million. The transaction is expected to close on March 1, 2016.

Associated Home Care, founded in 1991, is the leading private-duty agency in Greater Boston. Its 1,500 employees deliver care to 5,000 seniors daily, in homes throughout Eastern, Central, and Southern Massachusetts. Associated Home Care has corporate headquarters in North Andover and nine branch offices located in Beverly, Boston, Burlington, Leominster, Marblehead, Middleboro, Springfield, Worcester and Fall River. The Company generates approximately $40 million in annualized revenues.

Associated Home Care Chief Executive, Officer Michael Trigilio, along with his experienced management team, will continue to lead Associated Home Care. Trigilio will also oversee Amedisys’ new Personal Care Division to expand the Company’s private-duty capabilities throughout the country.

“This is our first acquisition of a private-duty company and an important step in realizing our long-term strategy,” stated Amedisys President and Chief Executive Officer Paul Kusserow. “Entering this complementary business line will also enhance our home health and hospice businesses in Massachusetts. This will improve the continuity of care our patients receive as their clinical needs change between skilled nursing and private-duty care over time – bringing even more value to our patients, referral sources and payers. We believe that private duty services are highly synergistic with our core skilled home health and hospice businesses, and that by acquiring these capabilities in one of our most successful regions we will realize these benefits quickly. Based on their strong track record of organic growth and integrating tuck-in acquisitions, we believe Associated Home Care is the right team to lead our efforts to grow this capability in our other core markets.”

“We are very excited to join Amedisys,” said Associated Home Care Chief Executive Officer Michael Trigilio. “For years we have been trying to identify the best way to add home health and hospice to our client service delivery. Amedisys will offer us the depth of support and range of resources available from one of the nation’s largest home healthcare and hospice providers. This gives us the clinical expertise, corporate infrastructure and stability to expand the range of services we provide in the communities we serve and beyond. Both organizations will benefit from each other’s expertise and enhance our collective delivery of care.”

Amedisys will provide further detail during its fourth quarter 2015 earnings conference call.

About Amedisys:

Amedisys, Inc. (NASDAQ:AMED) is a “health care at home” company delivering personalized home health and hospice care to more than 360,000 patients each year. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. For more information about Amedisys, please visit: http://www.amedisys.com. We use our company website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and


accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission (“SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).

About Associated Home Care:

Associated Home Care (AHC) has provided quality in-home senior care services since 1991. As a family-owned and operated company, AHC is committed to providing the highest level of assistance in all aspects of home care by providing a wide range of customized services from companionship to around-the-clock in-home care. With corporate office headquarters in North Andover and additional branch offices growing throughout Eastern, Central, and Southern Massachusetts, AHC is able to serve seniors, those with disabilities and their families in over 250+ communities. For more information about Associated Home Care, please visit http://www.associatedhomecare.com.

###

Media Contact:

Kendra Kimmons

Marketing & Communications

225-299-3720

kendra.kimmons@amedisys.com

David Castille

Investor Relations

225-299-3665

david.castille@amedisys.com

GRAPHIC 3 g137301img1.jpg GRAPHIC begin 644 g137301img1.jpg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g137301img2.jpg GRAPHIC begin 644 g137301img2.jpg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�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end